Dimethylamine

Dimethylamine

SCHEMBL27944752

CCC(O)c1cccc(Cl)c1.CNC

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.52
ADRB3 P13945 9/20 0.50
ADRB1 P08588 8/20 0.50
ADRB2 P07550 5/20 0.50
SLC2A1 P11166 2/20 0.49
SLC6A2 P23975 2/20 0.46
SLC6A4 P31645 2/20 0.46
HIF1A Q16665 3/20 0.45
HTR1A P08908 1/20 0.45
ADRA2A P08913 1/20 0.45
TSHR P16473 1/20 0.45
ADRA2B P18089 1/20 0.45
ADRA2C P18825 1/20 0.45
NFKB1 P19838 1/20 0.45
DRD1 P21728 1/20 0.45
HTR7 P34969 1/20 0.45
ADRA1A P35348 1/20 0.45
ADRA1B P35368 1/20 0.45
DRD3 P35462 1/20 0.45
RAB9A P51151 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3482675 0.94 LMNA (0.57) LMNAADRB3ADRB1ADRB2SLC2A1
SCHEMBL3482807 0.94 LMNA (0.57) LMNAADRB3ADRB1ADRB2SLC2A1
SCHEMBL867222 0.94 LMNA (0.57) LMNAADRB3ADRB1ADRB2SLC2A1
SCHEMBL3702012 0.82 ADRB1 (0.67) LMNAADRB3ADRB1ADRB2SLC2A1
SCHEMBL16679636 0.82 ADRB1 (0.67) LMNAADRB3ADRB1ADRB2SLC2A1
SCHEMBL11595350 0.80 LMNA (0.70) LMNAADRB3ADRB1ADRB2HIF1A
SCHEMBL13849942 0.80 ADRB1 (0.48) LMNAADRB3ADRB1ADRB2SLC2A1
SCHEMBL13849930 0.80 ADRB1 (0.48) LMNAADRB3ADRB1ADRB2SLC2A1
SCHEMBL14402491 0.80 ADRB1 (0.48) LMNAADRB3ADRB1ADRB2SLC2A1
SCHEMBL6690481 0.80 ADRB1 (0.48) LMNAADRB3ADRB1ADRB2SLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103664816-B The one kettle way asymmetric synthesis technique of hiv reverse transcriptase inhibitor Sustiva compounds SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2016-03-02 CN disclosed
CN-102584801-B One-pot asymmetric synthesis process of HIV reverse transcriptase inhibitor efavirenz compounds SHANGHAI INST ORGANIC CHEM 2015-02-18 CN disclosed
CN-103664816-A One-pot asymmetric synthetic process of HIV (Human Immunodeficiency Virus) reverse transcriptase inhibitor efavirenz compound SHANGHAI INST ORGANIC CHEM 2014-03-26 CN disclosed